Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.88733 | 64 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.6709 | 62 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.743 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.72895 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.705 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.97529 | 65 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.95535 | 65 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.79411 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.75247 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.77147 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.76619 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.64958 | 62 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.0007 | 66 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.78963 | 63 |